8/103 sources · 3 publishersUpdated Nov 5, 11:39 UTC
Sotera Health posts Q3 2026 earnings beat and reaffirms full‑year outlook
Sotera Health reported third‑quarter 2026 results with adjusted EPS of $0.29, topping analyst estimates by $0.02. Revenue reached $324.89 million, a 4.4% year‑over‑year increase and above consensus. The company said operating margin held at 35.9% and free‑cash‑flow margin rose to 17.8%. It also reaffirmed its full‑year 2026 revenue and EPS guidance.
Why it matters
The earnings beat and the reaffirmed FY‑2026 guidance suggest the company expects to maintain its performance trajectory, which may support investor confidence. The beat also triggered a notable share price jump, indicating market reaction to the results.
Key facts
- 1Adjusted EPS was $0.29, beating estimates by $0.02. seekingalpha.com
- 2Revenue was $324.89 million, up 4.4% year‑over‑year. seekingalpha.com
- 3Adjusted EBITDA increased 3.9% from the prior period. seekingalpha.com
- 4Operating margin remained steady at 35.9%. finance.yahoo.com
- 5Free cash flow margin improved to 17.8%. finance.yahoo.com
- 6The company reconfirmed its full‑year 2026 revenue and EPS guidance. finance.yahoo.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.